Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
Submit an article Journal homepage
170
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Two new 19-hydroxy bufadienolides with cytotoxic activity from the skins of Bufo melanosticus

Lingjie Menga Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, China;c Department of Biochemistry and Molecular Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Sanhua Lia Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Qinghong Konga Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Mei Wanga Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Xiaoke Zhanga Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Xinting Zhua Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;c Department of Biochemistry and Molecular Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Wei Yua Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Nian Jianga Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Zeli Chunb Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
,
Nian Lia Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, ChinaView further author information
&
Yun Liua Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou, China;b Research Center for Medicine & Biology, Zunyi Medical University, Zunyi, Guizhou, China;c Department of Biochemistry and Molecular Biology, Zunyi Medical University, Zunyi, Guizhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8615-4710View further author information
ORCID Icon show all
Pages 4894-4900 | Received 05 Nov 2019, Accepted 03 Mar 2020, Published online: 23 Mar 2020

References

  • Akizawa T, Mukai T, Matsukawa M, Yoshioka M, Morris JF, Butler VP. 1994. Structures of novel bufadienolides in the eggs of a toad, Bufo marinus. Chem Pharm Bull. 42(3):754–756.
  • Cui X, Inagaki Y, Xu H, Wang D, Qi F, Kokudo N, Fang D, Tang W. 2010. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells. Biol Pharm Bull. 33(10):1728–1732.
  • Cao X-T, Wang D, Wang N, Dai Y-H, Cui Z. 2009. Water-soluble constitutions from the Skin of Bufo bufo gargarizans Cantor. Chin J Nat Med. 7(3):181–183.
  • Dai YH, Shen B, Xia MY, Wang AD, Chen YL, Liu DC, Wang D. 2016. A new indole alkaloid from the toad venom of Bufo bufo gargarizans. Molecules. 21(3):349–353.
  • Editorial Committee of the Administration Bureau of Traditional Chinese Medicine. 1999. Chinese Materia Medica (Zhonghua Bencao). Shanghai: Shanghai Science and Technology Press; Vol. 26, p 360–362.
  • Li BJ, Tian HY, Zhang DM, Lei YH, Wang L, Jiang RW, Ye WC. 2015. Bufadienolides with cytotoxic activity from the skins of Bufo bufo gargarizans. Fitoterapia. 105:7–15.
  • Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, et al. 2009. Pilot study of Huachansu in patients with hepatocellular carcinoma, non small-cell lung cancer, or pancreatic cancer. Cancer. 115(22):5309–5318.
  • Meng L, Jiang N, Yu C, Li S, Chun Z, Zhu X, Song C, Xiao Y, Hui J, Qin Y, et al. 2019. Bufadienolides from the skins of Bufo melanosticus and their cytotoxic activity. Phytochem Lett. 31:73–77.
  • Nogawa T, Kamano Y, Yamashita A, Pettit GR. 2001. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug ch’an su. J Nat Prod. 64(9):1148–1152.
  • Peng P, Lv J, Cai C, Lin S, Zhuo E, Wang S. 2017. Cinobufagin, a bufadienolide, activates ROS-mediated pathways to trigger human lung cancer cell apoptosis in vivo. Rsc Adv. 7(40):25175–25181.
  • Qi F, Li A, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W. 2011. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol. 11(3):342–349.
  • Qi F, Li A, Zhao L, Xu H, Inagaki Y, Wang D, Cui X, Gao B, Kokudo N, Nakata M, et al. 2010. Cinobufacini, an aqueous extract from Bufo bufo gargarizans cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. J Ethnopharmacol. 128(3):654–661.
  • Shimada K, Ishii N, Nambara T. 1986. Occurrence of bufadienolides in the skin of bufo viridis Laur. Chem Pharm Bull. 34(8):3454–3457.
  • Sun T, Zhan B, Gao Y. 2015. A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria. Gene. 571(2):172–177.
  • Tian HY, Ruan LJ, Yu T, Zheng QF, Chen NH, Wu RB, Zhang XQ, Wang L, Jiang RW, Ye WC. 2017. Bufospirostenin A and Bufogargarizin C, steroids with rearranged skeletons from the toad Bufo bufo gargarizans. J Nat Prod. 80(4):1182–1186.
  • Tian HY, Wang L, Zhang XQ, Zhang DM, Wang Y, Liu JS, Jiang RW, Ye WC. 2010. New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans. Steroids. 75(12):884–890.
  • Tian HY, Luo SL, Liu JS, Wang L, Wang Y, Zhang DM, Zhang XQ, Jiang RW, Ye WC. 2013. C23 steroids from the venom of Bufo bufo gargarizans. J Nat Prod. 76(10):1842–1847.
  • Verpoorte R, Kinh PQ, Svendsen AB. 1979. Chemical constituents of vietnamese toad venom collected from bufo melanostictus schneider. J. Ethnopharmacol. 1(2):197–202.
  • Wang YM, Li ZY, Wang JJ, Wu XY, Gao HM, Wang ZM. 2015. Bufadienolides and polyhydroxycholestane derivatives from Bufo bufo gargarizans. J Asian Nat Prod Res. 17(4):364–376.
  • Wang DL, Qi FH, Tang W, Wang FS. 2011. Chemical constituents and bioactivities of the skin of Bufo bufo gargarizans cantor. Chem Biodivers. 8(4):559–567.
  • Zhang PW, Tian HY, Nie QL, Wang L, Zhou SW, Ye WC, Zhang DM, Jiang RW. 2016. Structures and inhibitory activity against breast cancer cells of new bufadienolides from the eggs of toad Bufo bufo gargarizans. RSC Adv. 6(96):93832–93841.
  • Zhao HY, Wu FK, Qiu YK, Wu Z, Jiang YT, Chen JY. 2010. Studies on cytotoxic constituents from the skin of the toad Bufo bufo gargarizans. J Asian Nat Prod Res. 12(9):793–800.
  • Zhang PW, Jiang RW, Ye WC, Tian HY. 2014. Bufadienolides from venom of Bufo bufo gargarizans. Zhongguo Zhong Yao Za Zhi. 39(5):841–845.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.